Medical Annuity Could Be Best Option for Investor With Cancer

Dear Mr. Berko: I have cancer, and the prognosis is not good.

I am 71 and might be able to live for another seven to eight years with proper care, which, as you know, is very costly. This cost is hard on my family and draining our income. I have $330,000 invested in the stock market (mostly blue chips), and the dividends earn me about $11,000 annually. My pension, Social Security and investments do not cover my expenses today. I need more income to live on, and my investments must be very safe. My stockbroker suggested a single premium immediate annuity that would give me $1,750 a month, or $21,000 a year, on an investment of $280,000. That would be just perfect. He would have me invest the remaining $50,000 in five high-yielding stocks (names enclosed) paying over 10 percent. I know there are much higher-paying stocks, but I don’t know which ones are good and safe. My daughter suggested I write you for recommendations because you would know some good, safe stocks paying 10 percent or more. Please answer as quickly as you can. We’re nervous and hanging in libido waiting for your answer. — PM, Buffalo, N.Y.

Dear PM: “Hanging in libido,” now that’s interesting.

There are good companies paying over 10 percent that I can recommend, but I can’t recommend any “good and safe” companies paying over 10 percent. Among the many dictums in this business is, “The higher the yield the higher the risk.” Of the five high yielders your broker recommends, four are neither good nor safe, so their prices and dividends will eventually fall. His New Residential Investment Corp. (NRZ-$16.30) recommendation, paying 12.4 percent, is the only one to keep. Then consider the real estate investment trust Ellington Residential Mortgage (EARN-$14.50), yielding 11.1 percent, Vistra Energy (VST-$17.25), yielding 13 percent, Telstra (TLSYY-$14), yielding 8 percent, and WhiteHorse Finance (WHF-$14.10), yielding 10 percent. These issues are much less unsafe than those he recommended. Still, they’re quite iffy.

And there’s a better annuity solution. It’s called a medically underwritten single premium immediate annuity, though your broker probably knows nothing of them because the commissions are embarrassingly lower than that of the typical SPIA. In exchange for handing over $280,000 for a medical annuity, you would be paid a much higher income than you would receive from the usual SPIA. A medical SPIA doesn’t have hidden fees. And in addition to the reasonable commission costs, the administration fees are low. A medical annuity is basically a straightforward, uncomplicated investment.

However, to qualify for a medical SPIA, you must have a chronic illness along the lines of advanced diabetes, lung cancer, HIV, Lou Gehrig’s disease, kidney failure, Parkinson’s disease or Hodgkin lymphoma. Though this sounds foreboding, a medical annuity can be a life-giver. A 71-year-old purchasing a regular $280,000 SPIA would receive between $1,700 and $1,800 a month, or between $20,400 and $21,600 annually, depending on the company issuing the policy. Yes, that’s a lot more than the $11,000 a year you’re getting from the dividends in your stock portfolio, but the payouts on a medical SPIA — because of your anticipated shorter life span — would be significantly more than those of the SPIA recommended by your broker. A $280,000 investment in a medical annuity could pay you between $2,100 and $2,600 a month.

There is a downside. If you pass away after purchasing a standard medical annuity, the payouts end immediately upon your death. You can structure this annuity to pay survivor benefits, but only if you’re willing to accept lower monthly payments. That said, the lower payments would still be higher than the payouts from a standard SPIA.

Mutual of Omaha, MetLife and Genworth Financial are among the very few companies offering medical annuities. However, I expect that other insurers will begin selling them soon.

Please address your financial questions to Malcolm Berko, P.O. Box 8303, Largo, FL 33775, or email him at mjberko@yahoo.com. To find out more about Malcolm Berko and read features by other Creators Syndicate writers and cartoonists, visit the Creators Syndicate website at www.creators.com.

You May Also Like

American Heritage Schools Hosts Virtual Job Fair for Teachers

Educators around the U.S. are invited to attend.

Editor’s Letter: A Man of Nearly Unlimited Interests

Kevin Kaminski, Lifestyle Group Editor, was an honor to the profession of journalism.

Editor’s Letter: Face Time

The importance of showing up.

Kevin Kaminski (1963-2023)

The entire Lifestyle Media team—which includes South Florida Business & Wealth—is mourning the sudden loss of our extraordinary Lifestyle magazine Group Editor, Kevin Kaminski. We will honor his legacy in

Other Posts

Sommsation Celebrates “Liquid Art” During Miami Art Week

The state-of-the-art wine experience platform is the official Wine Experience sponsor of SCOPE Art Show 2023.

September Job Gains Good News for South Florida 

“September’s job report was the strongest since January of this year and showed an acceleration in late summer hiring,” says Tom Jalics, senior vice president, managing director and chief investment strategist at Fifth Third Private Bank.  

BE Connected Summit Aims to Help Small Business Owners

The group consists of powerhouse event professionals who wholeheartedly believe in the value of community. 

Editor’s Letter Expressions of Gratitude

We couldn’t do any of this without our readers and partners.

Drew Limsky

Drew Limsky



Drew Limsky joined Lifestyle Media Group in August 2020 as Editor-in-Chief of South Florida Business & Wealth. His first issue of SFBW, October 2020, heralded a reimagined structure, with new content categories and a slew of fresh visual themes. “As sort of a cross between Forbes and Robb Report, with a dash of GQ and Vogue,” Limsky says, “SFBW reflects South Florida’s increasingly sophisticated and dynamic business and cultural landscape.”

Limsky, an avid traveler, swimmer and film buff who holds a law degree and Ph.D. from New York University, likes to say, “I’m a doctor, but I can’t operate—except on your brand.” He wrote his dissertation on the nonfiction work of Joan Didion. Prior to that, Limsky received his B.A. in English, summa cum laude, from Emory University and earned his M.A. in literature at American University in connection with a Masters Scholar Award fellowship.

Limsky came to SFBW at the apex of a storied career in journalism and publishing that includes six previous lead editorial roles, including for some of the world’s best-known brands. He served as global editor-in-chief of Lexus magazine, founding editor-in-chief of custom lifestyle magazines for Cadillac and Holland America Line, and was the founding editor-in-chief of Modern Luxury Interiors South Florida. He also was the executive editor for B2B magazines for Acura and Honda Financial Services, and he served as travel editor for Conde Nast. Magazines under Limsky’s editorship have garnered more than 75 industry awards.

He has also written for many of the country’s top newspapers and magazines, including The New York Times, Washington Post, Los Angeles Times, Miami Herald, Boston Globe, USA Today, Worth, Robb Report, Afar, Time Out New York, National Geographic Traveler, Men’s Journal, Ritz-Carlton, Elite Traveler, Florida Design, Metropolis and Architectural Digest Mexico. His other clients have included Four Seasons, Acqualina Resort & Residences, Yahoo!, American Airlines, Wynn, Douglas Elliman and Corcoran. As an adjunct assistant professor, Limsky has taught journalism, film and creative writing at the City University of New York, Pace University, American University and other colleges.